MN

Manisha Nandwani

Director Additional Director DIN 00932215
DIN 00932215 First appointment May 2004 Primary industry Real Estate and Construction
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2004
Shareholding value •••• Premium profile

About Manisha Nandwani

Data last updated:

Manisha Nandwani was an Additional Director at Rabs Buildcon Private Limited (2015–2019) and Director at Ethnotech Pharmaceuticals Private Limited (2004–2008). The companies operate in Real Estate and Construction and Healthcare.

DIN 00932215
Primary Designation Additional Director
Industry Real Estate and Construction
First Appointment 01 May 2004

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rabs Buildcon Private Limited U45200MP2012PTC027745
Additional Director13 Mar 20152012₹3.25 Cr (FY 2025)Active
Director01 May 20042002Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Rabs Buildcon Private Limited
Ethnotech Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Manisha Nandwani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manisha Nandwani

Manisha Nandwani was first appointed on 01 May 2004 as Director at Ethnotech Pharmaceuticals Private Limited. The most recent appointment on record is 13 Mar 2015 at Rabs Buildcon Private Limited.

Manisha Nandwani held 2 earlier board appointments: Rabs Buildcon Private Limited (Additional Director, 13 Mar 2015 to 12 Jun 2019); Ethnotech Pharmaceuticals Private Limited (Director, 01 May 2004 to 11 May 2008).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available